Recent News

• 02.04.2026 - BullFrog AI to Unveil New Precision AI Capability
• 01.27.2026 - BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
• 01.06.2026 - BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
• 12.30.2025 - BullFrog AI Publishes Annual Letter to Shareholders
• 11.18.2025 - BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights
• 11.12.2025 - BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
• 10.30.2025 - Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30
• 09.30.2025 - BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module

Recent Filings

• 12.30.2025 - 8-K Current report
• 12.30.2025 - EX-99.1 EX-99.1
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.25.2025 - EFFECT Notice of Effectiveness
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 10.24.2025 - 8-K Current report
• 10.10.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 10.09.2025 - 8-K Current report
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities